Literature DB >> 22328240

Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique.

Young Tag Ko1, Ulrich Bickel.   

Abstract

Liposome-encapsulated polyplex system represents a promising delivery system for oligonucleotide-based therapeutics such as siRNA and asODN. Here, we report a novel method to prepare liposome-encapsulated cationic polymer/oligonucleotide polyplexes based on the reverse-phase evaporation following organic extraction of the polyplexes. The polyplexes of polyethylenimine and oligonucleotide were first formed in aqueous buffer at an N/P ratio of 6. The overall positively charged polyplexes were then mixed with the anionic phospholipids in overall organic media. The overall organic environment and electrostatic interaction between anionic phospholipids and positively charged polyplexes resulted in inverted micelle-like particles with the polyplexes in the core. After phase separation, the hydrophobic particles were recovered in organic phase. Reverse-phase evaporation of the organic solvent in the presence of hydrophilic polymer-grafted lipids resulted in a stable aqueous dispersion of hydrophilic lipid-coated particles with the polyplex in the core. Transmission electron microscopy visualization revealed spherical structures with heavily stained polyplex cores surrounded by lightly stained lipid coats. The lipid-coated polyplex particles showed colloidal stability, complete protection of the loaded oligonucleotide molecules from enzymatic degradation, and high loading efficiency of more than 80%. Thus, this technique represents an alternative method to prepare lipid-coated polyplex particles as a delivery system of oligonucleotide therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328240      PMCID: PMC3364371          DOI: 10.1208/s12249-012-9757-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

Review 1.  Progress towards a synthetic virus for systemic gene therapy.

Authors:  I MacLachlan; P Cullis; R W Graham
Journal:  Curr Opin Mol Ther       Date:  1999-04

2.  In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes.

Authors:  S Li; L Huang
Journal:  Gene Ther       Date:  1997-09       Impact factor: 5.250

3.  In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.

Authors:  R Morishita; T Sugimoto; M Aoki; I Kida; N Tomita; A Moriguchi; K Maeda; Y Sawa; Y Kaneda; J Higaki; T Ogihara
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

4.  Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer.

Authors:  R J Lee; L Huang
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

5.  Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor.

Authors:  P Bandyopadhyay; X Ma; C Linehan-Stieers; B T Kren; C J Steer
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

6.  Stabilized plasmid-lipid particles: construction and characterization.

Authors:  J J Wheeler; L Palmer; M Ossanlou; I MacLachlan; R W Graham; Y P Zhang; M J Hope; P Scherrer; P R Cullis
Journal:  Gene Ther       Date:  1999-02       Impact factor: 5.250

Review 7.  Long-circulating vectors for the systemic delivery of genes.

Authors:  D B Fenske; I MacLachlan; P R Cullis
Journal:  Curr Opin Mol Ther       Date:  2001-04

8.  A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity.

Authors:  D Fischer; T Bieber; Y Li; H P Elsässer; T Kissel
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

9.  Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA.

Authors:  James Heyes; Lorne Palmer; Kitty Chan; Cory Giesbrecht; Lloyd Jeffs; Ian MacLachlan
Journal:  Mol Ther       Date:  2007-02-13       Impact factor: 11.454

10.  Quenching of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole-modified Na+/K+-ATPase reveals a higher accessibility of the low-affinity ATP-binding site.

Authors:  H Linnertz; P Urbanova; E Amler
Journal:  FEBS Lett       Date:  1997-12-15       Impact factor: 4.124

View more
  4 in total

1.  Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.

Authors:  Anish Babu; Anupama Munshi; Rajagopal Ramesh
Journal:  Drug Dev Ind Pharm       Date:  2017-05-19       Impact factor: 3.225

2.  Folate-targeted liposome encapsulating chitosan/oligonucleotide polyplexes for tumor targeting.

Authors:  Ji Hee Kang; Gantumur Battogtokh; Young Tag Ko
Journal:  AAPS PharmSciTech       Date:  2014-05-22       Impact factor: 3.246

3.  In vitro characterization of chemokine-loaded liposomes.

Authors:  Angel J Rubio; Xuemei Zhong; Tyrone M Porter
Journal:  Cogent Biol       Date:  2019-09-11

4.  VCAM-1 Targeted Lipopolyplexes as Vehicles for Efficient Delivery of shRNA-Runx2 to Osteoblast-Differentiated Valvular Interstitial Cells; Implications in Calcific Valve Disease Treatment.

Authors:  Geanina Voicu; Daniela Rebleanu; Cristina Ana Mocanu; Gabriela Tanko; Ionel Droc; Cristina Mariana Uritu; Mariana Pinteala; Ileana Manduteanu; Maya Simionescu; Manuela Calin
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.